Antacid use and subclinical interstitial lung disease: the MESA study

Eur Respir J. 2017 May 19;49(5):1602566. doi: 10.1183/13993003.02566-2016. Print 2017 May.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antacids / therapeutic use*
  • Female
  • Gastroesophageal Reflux / complications*
  • Gastroesophageal Reflux / drug therapy
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Linear Models
  • Lung Diseases, Interstitial / complications*
  • Lung Diseases, Interstitial / drug therapy*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Proton Pump Inhibitors / therapeutic use
  • Risk Factors

Substances

  • Antacids
  • Histamine H2 Antagonists
  • Proton Pump Inhibitors